Health and Wellness

A six-month trial found improved pain scores after three months of Pycnogenol in women with osteopenia or stable osteoporosis; longer-term effects remain unclear.

• Comfort a Life Team
• October 16, 2026

A 783-patient phase III trial found more heartburn-free days with tegoprazan than placebo in non-erosive reflux disease over four weeks.

• Comfort a Life Team
• October 16, 2026

A 67-person randomized study found 89.2% use of delivered produce, compared with 28.3% when participants had to collect it at a market.

• Comfort a Life Team
• October 16, 2026

A Lancet Neurology paper proposes coordinated, long-term monitoring after traumatic brain and spinal cord injuries, including screenings and care navigators.

• Comfort a Life Team
• October 15, 2026

A review reports possible links between PMOS and Alzheimer’s-related changes, but says metabolic conditions may explain the association.

• Comfort a Life Team
• October 15, 2026

POSEIDON registry data found hsCRP at or above 2 mg/L in about half of U.S. heart failure participants, while targeted drug trials have disappointed.

• Comfort a Life Team
• October 15, 2026

The ICRAKI trial stopped early after initial intermittent hemodialysis was linked to higher 90-day mortality than continuous therapy in critically ill patients.

• Comfort a Life Team
• October 15, 2026

A Chalmers-led study links TRL and Lp(a) protein patterns to inflammatory and blood-vessel processes, offering clues to heart risk beyond LDL.

• Comfort a Life Team
• October 14, 2026

An observational study found that greater daily walking after inpatient surgery was associated with fewer complications and readmissions.

• Comfort a Life Team
• October 14, 2026

Northwestern researchers report that a water-capped hotspot in tau helps misfolded proteins recruit and align more tau in lab experiments.

• Comfort a Life Team
• October 14, 2026